Sector consensus Akeso, Inc.

Equities

Market Closed - Hong Kong S.E. Other stock markets 01:38:14 09/07/2025 pm IST			5-day change	1st Jan Change
109.80 ^HKD	0.00%		+19.41%	+80.89%

03/07	Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports	RE
03/07	Akeso's First Bispecific Adc (Trop2/Nectin4 Adc) Enters Clinical Trials, Strengthening Leadership in 'Io+Adc'2.0 Strategy	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Average Target P.	Ecart obj. / dr	Nbr of analysts
AKESO, INC.		HK$96.14	-4.06%	20
ARGENX SE		€667.33	+43.79%	16
WUXI APPTEC CO., LTD.		CN¥83.08	+18.02%	18
BIONTECH SE		$116.8	+22.55%	21
INSMED INCORPORATED		$113.22	+17.76%	18
SUMMIT THERAPEUTICS INC.		$25.65	+52.36%	9
WUXI BIOLOGICS (CAYMAN) INC.		HK$27.24	+16.12%	26
GENMAB A/S		DKK 1,936.2	+42%	16
EXELIXIS, INC.		$45	+3.42%	19
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.		HK$321.97	-6.13%	16
VERONA PHARMA PLC		$119.09	+37.11%	11
LEGEND BIOTECH CORPORATION		$75.07	+100.24%	20
MADRIGAL PHARMACEUTICALS, INC.		$423.14	+47.17%	14
PHARMAESSENTIA CORPORATION		NT$700.5	+33.68%	4
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.		CN¥99.04	+7.28%	2
BIOCON LIMITED		₹379.2	+2.67%	20
NUVALENT, INC.		$117.3	+48.91%	10
REMEGEN CO., LTD.		HK$36.44	-41.28%	15
SINOCELLTECH GROUP LIMITED	-	CN¥49	-38.11%	2
Average		285.86	+21.24%	15
Weighted average by Cap.		305.81	+24.73%	16